{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:06Z","timestamp":1786993986614,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.maturitas.2024.107941","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T04:49:53Z","timestamp":1707972593000},"page":"107941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-5368","authenticated-orcid":false,"given":"Megan","family":"Crichton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3827-7438","authenticated-orcid":false,"given":"Thusharika","family":"Dissanayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8230","authenticated-orcid":false,"given":"Wolfgang","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8567-4716","authenticated-orcid":false,"given":"Elizabeth","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-3017","authenticated-orcid":false,"given":"Nikolaj","family":"Travica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-0931","authenticated-orcid":false,"given":"Alison","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-9707","authenticated-orcid":false,"given":"Elizabeth","family":"Isenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-8504","authenticated-orcid":false,"given":"Patsy","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-5068","authenticated-orcid":false,"given":"Skye","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2024.107941_bb0005","first-page":"6813","article-title":"Fear of cancer recurrence: a qualitative systematic review and meta-synthesis of patients\u2019 experiences","author":"Almeida","year":"2019","journal-title":"Clin. Psychol. Rev."},{"issue":"8","key":"10.1016\/j.maturitas.2024.107941_bb0010","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/annonc\/mdx265","article-title":"First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study","volume":"28","author":"Zhu","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.maturitas.2024.107941_bb0015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41380-019-0595-x","article-title":"Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.maturitas.2024.107941_bb0020","doi-asserted-by":"crossref","unstructured":"Berk et al., 2023. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. , World Psychiatry. In Press.","DOI":"10.1002\/wps.21110"},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12874-021-01352-4","article-title":"Symptom clusters among cancer survivors: what can machine learning techniques tell us?","volume":"21","author":"Neijenhuijs","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-020-05522-8","article-title":"Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics","volume":"180","author":"Bjerkeset","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","article-title":"Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority","volume":"19","author":"Niedzwiedz","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12913-023-09056-9","article-title":"Disparities in the medical expenditures of patients with cancer and concomitant mental disorder: analyzing the effects of diagnosis sequence order","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.maturitas.2024.107941_bb0045","doi-asserted-by":"crossref","unstructured":"B.L. Andersen, C. Lacchetti, K. Ashing, J.S. Berek, B.S. Berman, S. Bolte, D.S. Dizon, B. Given, L. Nekhlyudov, W. Pirl, A.L. Stanton, and J.H. Rowland, 2023. Management of Anxiety and Depression in adult survivors of Cancer: ASCO guideline update, J. Clin. Oncol. Jco2300293.https:\/\/doi.org\/10.1200\/jco.23.00293.","DOI":"10.1200\/JCO.23.00293"},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/0284186X.2021.1992008","article-title":"Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys","volume":"61","author":"Vehling","year":"2022","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/mdx526","article-title":"The use of antidepressants in oncology: a review and practical tips for oncologists","volume":"29","author":"Grassi","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0706743719895195","article-title":"Cannabidiol as a treatment for mood disorders: a systematic review","volume":"65","author":"Pinto","year":"2020","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12888-019-2409-8","article-title":"Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review","volume":"20","author":"Sarris","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/IJPC.IJPC_100_17","article-title":"Complementary therapies for symptom Management in Cancer Patients","volume":"23","author":"Satija","year":"2017","journal-title":"Indian J. Palliat. Care"},{"issue":"3","key":"10.1016\/j.maturitas.2024.107941_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3747\/co.25.3983","article-title":"Rates of cannabis use in patients with cancer","volume":"25","author":"Martell","year":"2018","journal-title":"Curr. Oncol."},{"issue":"9","key":"10.1016\/j.maturitas.2024.107941_bb0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/COC.0000000000000718","article-title":"Medical Cannabis in Cancer patients: a survey of a community hematology oncology population","volume":"43","author":"Macari","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.maturitas.2024.107941_bb0085","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/cncr.33794","article-title":"Cannabis use among cancer survivors in the United States: analysis of a nationally representative sample","volume":"127","author":"Do","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2024.107941_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00520-023-07628-3","article-title":"Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression","volume":"31","author":"De Feo","year":"2023","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.maturitas.2024.107941_bb0095","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88105906","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst. Rev."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2046-4053-4-5","article-title":"Using text mining for study identification in systematic reviews: a systematic review of current approaches","volume":"4","author":"O\u2019Mara-Eves","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.maturitas.2024.107941_bb0110","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","volume":"vol. Volume 5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.maturitas.2024.107941_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.maturitas.2024.107941_bb0120","doi-asserted-by":"crossref","unstructured":"J.A.C. Sterne, Hern\u00e1n, M.A., Reeves, B.C., Savovi\u0107, J., Berkman, N.D., Viswanathan, M., Henry, D., Altman, D.G., Ansari, M.T., Boutron, I., Carpenter, J.R., Chan, A.W., Churchill, R., Deeks, J.J., Hr\u00f3bjartsson, A., Kirkham, J., J\u00fcni, P., Loke, Y.K., Pigott, T.D., Ramsay, C.R., Regidor, D., Rothstein, H.R., Sandhu. L., Santaguida, P.L., Sch\u00fcnemann, H.J., Shea, B., Shrier, I., Tugwell, P., Turner, L., Valentine, J.C., Waddington, H., Waters, E., Wells, G.A., Whiting, P.F., Higgins, J.P.T., 2016. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions., BMJ 355.https:\/\/doi.org\/10.1136\/bmj.i4919.","DOI":"10.1136\/bmj.i4919"},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the journal of clinical epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.maturitas.2024.107941_bb0130","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, And W. VA, Cochrane handbook for systematic reviews of interventions version 6.4 (updated august 2023). 2023, Cochrane."},{"key":"10.1016\/j.maturitas.2024.107941_bb0135","series-title":"Melbourne","author":"R. Ryan, Heterogeneity and Subgroup Analyses in Cochrane Consumers and Communication Group Reviews: Planning the Analysis at Protocol Stage","year":"2016"},{"key":"10.1016\/j.maturitas.2024.107941_bb0140","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14120","author":"Jakobsen","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"9","key":"10.1016\/j.maturitas.2024.107941_bb0145","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0150","first-page":"109","article-title":"Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting","volume":"69","author":"Citron","year":"1985","journal-title":"Cancer Treat. Rep."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with Nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial","volume":"125","author":"C\u00f4t\u00e9","year":"2016","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2125.1974.tb00257.x","article-title":"A pilot study of orally administered \u0394 trans tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus","volume":"1","author":"Davies","year":"1974","journal-title":"BRIT.J.CLIN.PHARMACOL."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0165","first-page":"319","article-title":"Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study","volume":"6","author":"Devine","year":"1987","journal-title":"Clin. Pharm."},{"issue":"14","key":"10.1016\/j.maturitas.2024.107941_bb0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF01487619","article-title":"Levonantradol for the treatment of chemotherapy-induced nausea and vomiting","volume":"61","author":"Gerhartz","year":"1983","journal-title":"Klin. Wochenschr."},{"issue":"5","key":"10.1016\/j.maturitas.2024.107941_bb0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/jpm.2019.0540","article-title":"An open-label pilot study testing the feasibility of assessing Total symptom burden in trials of cannabinoid medications in palliative care","volume":"23","author":"Good","year":"2020","journal-title":"J. Palliat. Med."},{"issue":"7","key":"10.1016\/j.maturitas.2024.107941_bb0180","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.22.01632","article-title":"Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of Cannabidiol oil for the relief of symptoms in advanced Cancer (MedCan1-CBD)","volume":"41","author":"Hardy","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2024.107941_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00257128","article-title":"Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy","volume":"13","author":"Heim","year":"1984","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl. B","key":"10.1016\/j.maturitas.2024.107941_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0305-7372(82)80032-7","article-title":"A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy","volume":"9","author":"Johansson","year":"1982","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J. Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.maturitas.2024.107941_bb0200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.maturitas.2024.107941_bb0205","article-title":"A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal Cannabis in patients with high grade gliomas","volume":"11649555","author":"Schloss","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0210","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/1097-0142(19820815)50:4<636::AID-CNCR2820500404>3.0.CO;2-4","article-title":"Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine","volume":"50","author":"Ungerleider","year":"1982","journal-title":"Cancer (philadelphia)."},{"issue":"2","key":"10.1016\/j.maturitas.2024.107941_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/00000421-198504000-00006","article-title":"THC or Compazine\u00ae for the cancer chemotherapy patient\u2014the UCLA study: part II: patient drug preference","volume":"8","author":"Ungerleider","year":"1985","journal-title":"Am. J. Clin. Oncol."},{"issue":"662","key":"10.1016\/j.maturitas.2024.107941_bb0220","first-page":"449","article-title":"The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy","volume":"91","author":"Colls","year":"1980","journal-title":"N. Z. Med. J."},{"issue":"2","key":"10.1016\/j.maturitas.2024.107941_bb0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jpainsymman.2015.10.004","article-title":"Minimal clinically important difference in the physical, emotional, and Total symptom distress scores of the Edmonton symptom assessment system","volume":"51","author":"Hui","year":"2016","journal-title":"J. Pain Symptom Manage."},{"issue":"6","key":"10.1016\/j.maturitas.2024.107941_bb0230","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.chest.2018.12.010","article-title":"Validity and responsiveness of the depression anxiety stress Scales-21 (DASS-21) in COPD","volume":"155","author":"Yohannes","year":"2019","journal-title":"Chest"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2024.107941_bb0235","first-page":"S34","article-title":"Clinical practice guidelines for the management of depression","volume":"59","author":"Gautam","year":"2017","journal-title":"Indian J. Psychiatry."},{"issue":"7","key":"10.1016\/j.maturitas.2024.107941_bb0240","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/add.15743","article-title":"Clinical management of cannabis withdrawal","volume":"117","author":"Connor","year":"2022","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.maturitas.2024.107941_bb0245","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.maturitas.2024.107941_bb0250","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.maturitas.2024.107941_bb0255","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177136-144","author":"Childs","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0260","first-page":"374","article-title":"Cannabis, a cause for anxiety?","volume":"18","author":"Sharpe","year":"2020","journal-title":"A critical appraisal of the anxiogenic and anxiolytic properties, Journal of Translational Medicine."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0265","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/ejn.14982","article-title":"The neuropharmacology of cannabinoid receptor ligands in central signaling pathways","volume":"55","author":"Brunt","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.maturitas.2024.107941_bb0270","doi-asserted-by":"crossref","unstructured":"S. Zou and U. Kumar, 2018. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system, Int. J. Mol. Sci. 19(3).https:\/\/doi.org\/10.3390\/ijms19030833.","DOI":"10.3390\/ijms19030833"},{"key":"10.1016\/j.maturitas.2024.107941_bb0275","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-57369-0_1","article-title":"Constituents of Cannabis sativa","volume":"12641-13","author":"Rock","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.maturitas.2024.107941_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","article-title":"The \u201centourage effect\u201d: terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders","volume":"18","author":"Ferber","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.maturitas.2024.107941_bb0285","article-title":"Myrcene-what are the potential health benefits of this Flavouring and aroma agent?","volume":"8699666","author":"Surendran","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.maturitas.2024.107941_bb0290","doi-asserted-by":"crossref","unstructured":"J. Kruger, L. Blavos, T. Castor, A. Wotring, V. Wagner-Greene, T. Glassman, and D. Kruger, 2019. Manipulation checking the munchies: validating self-reported dietary behaviors during Cannabis intoxication, Human Ethology. 3410-16.10.22330\/he\/34\/010-016.","DOI":"10.22330\/he\/34\/010-016"},{"issue":"9","key":"10.1016\/j.maturitas.2024.107941_bb0295","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881119862526","article-title":"Exploring the munchies: an online survey of users\u2019 experiences of cannabis effects on appetite and the development of a cannabinoid eating experience questionnaire","volume":"33","author":"Roberts","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.maturitas.2024.107941_bb0300","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/02692163221083437","article-title":"Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: a systematic review","volume":"36","author":"Razmovski-Naumovski","year":"2022","journal-title":"Palliat. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2024.107941_bb0305","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s13668-022-00436-x","article-title":"The endocannabinoid system and eating Behaviours: a review of the current state of the evidence","volume":"11","author":"Aguilera Vasquez","year":"2022","journal-title":"Current Nutrition Reports."},{"issue":"1","key":"10.1016\/j.maturitas.2024.107941_bb0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41398-020-0756-3","article-title":"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study","volume":"10","author":"Farokhnia","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.maturitas.2024.107941_bb0315","first-page":"6633","article-title":"Driving the need to feed: insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems","author":"Edwards","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"S2","key":"10.1016\/j.maturitas.2024.107941_bb0320","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1017\/S0022215116000402","article-title":"Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Talwar","year":"2016","journal-title":"J. Laryngol. Otol."},{"issue":"5","key":"10.1016\/j.maturitas.2024.107941_bb0325","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.maturitas.2024.107941_bb0330","doi-asserted-by":"crossref","unstructured":"M. Byun, E. Kim and J. Kim, 2021. Physical and mental health factors associated with poor nutrition in elderly Cancer survivors: insights from a Nationwide survey, Int. J. Environ. Res. Public Health 18(17).https:\/\/doi.org\/10.3390\/ijerph18179313.","DOI":"10.3390\/ijerph18179313"},{"key":"10.1016\/j.maturitas.2024.107941_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00293","article-title":"Cannabinoid receptor signaling in central regulation of feeding behavior: a Mini-review","volume":"11","author":"Koch","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.maturitas.2024.107941_bb0340","doi-asserted-by":"crossref","unstructured":"S. Pati, W. Irfan, A. Jameel, S. Ahmed and R.K. Shahid, 2023. Obesity and Cancer: a current overview of epidemiology, pathogenesis, outcomes, and management, cancers (Basel). 15(2).https:\/\/doi.org\/10.3390\/cancers15020485.","DOI":"10.3390\/cancers15020485"},{"issue":"9","key":"10.1016\/j.maturitas.2024.107941_bb0345","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00520-014-2204-5","article-title":"Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study","volume":"22","author":"Ancoli-Israel","year":"2014","journal-title":"Support. Care Cancer"},{"issue":"11","key":"10.1016\/j.maturitas.2024.107941_bb0350","doi-asserted-by":"crossref","first-page":"e2243848","DOI":"10.1001\/jamanetworkopen.2022.43848","article-title":"Placebo response and media attention in randomized clinical trials assessing Cannabis-based therapies for pain: a systematic review and Meta-analysis","volume":"5","author":"Gedin","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:13:32Z","timestamp":1742177612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512224000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":70,"alternative-id":["S0378512224000367"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.107941","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.107941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107941"}}